The effect of' tetramisole (hydrochloride of' racemic 2, 3, 5, 6,-tetrahydro-6-phenyl-imidazo [2, 1-bh 
The effect of' tetramisole (hydrochloride of' racemic 2, 3, 5, 6,-tetrahydro-6-phenyl-imidazo [2, 1-bh thiazole) on immunization was investigated in mice vaccinated by killed Brucella melitensis cells suspended in incomplete adjuvant. Immunity to Brucella abortus challenge was estimated by the reduction in number of B. abortus colonies per gram of spleen in those mice which escaped full immunization and also by calculation of mean infective doses for each group of mice. All tetramisole treatments significantly reduced the number of B. abortus live cells in spleen from infected mice. Tetramisole, injected twice (at the time of vaccination and 48 h later), induced a significant 3.5-fold increase of the protection brought about by Brucella vaccine alone. A single injection of 1.25 mg/kg at the time of vaccination resulted also in a significant increase of the immunity given by vaccination. No modifications of the vaccine potency were observed if tetramisole administration preceded vaccination. In such a mouse assay, tetramisole-induced stimulation was not accompanied by specific antibody increases, although measured by three serological tests.
Two phenyl-imidothiazole salts, tetramisole and levamisole, are synthetic nontoxic chemicals that exert a stimulatory effect on T lymphocytes and macrophages (7) (8) (9) . Tetramisole interferes with antigenic competition and nonspecific immunity and is effective in restoring an immunization that had been impaired after a prior unrelated infection (10) .
Tetramisole and levamisole may be of practical usefulness as vaccine adjuvants. The following experiment was designed to investigate the role of a single or of multiple tetramisole doses in modifying the immune response of mice to a bacterial vaccination. A Brucella vaccine and a Brucella abortus challenge were selected to avoid the remote possibility of false responses that may be due to preliminary inescapable contact of normal animals with antigens or cells of ubiquitous gram-negative organisms by inhalation or ingestion (2) . A good vaccine stimulation was obtained when tetramisole was injected at the time of vaccine, and an even more marked adjuvant action was observed following tetramisole administration 2 days after vaccination.
MATERIALS AND METHODS
Vaccine. Brucella melitensis H 38 vaccine, a suspension of Formalin-killed cells in incomplete adjuvant, was used throughout this study at a concentration of 15 x 10' cells/ml. This B. melitensis killed vaccine is of known potency against a B. abortus challenge (3) .
Tetramisole. Tetramisole, hydrochloride of racemic 2, 3, 5, 6-tetrahydro-6-phenyl-imidazo [2, 1-b] thiazole, was first known as a nontoxic and powerful antihelminthic drug (13 (5) .
Blood samples were obtained by aseptic transorbital puncture of the sphenoid sinus before autopsy.
RESULTS
Effects of tetramisole treatments in modifying mouse ID50 after B. abortus challenge. Tetramisole administered simultaneously with, or 48 h after, vaccination exerted a stimulatory effect on anti-Brucella vaccination. Indeed, H 38 vaccine alone (group 2) induced an immunity in mice so that the ID50 was 333 times (confidence limits from 2 x 105 to 8 x 105) higher than the ID50 of control mice (group 1), where confidence limits varied from 530 to 4,200 with a mean value of 1.5 x 103 live cells (Fig. 1) .
A significant difference was observed, at P = 0.05, between mice submitted to a single tetramisole treatment and mice immunized by H 38 alone. Indeed, 1.25 mg of tetramisole per kg given at the time of vaccination (group 6) multiplied by 833 the number of B. abortus organisms needed to infect 50% of the mice; in this group, confidence limits consisted of between 9 x 105 and 1.5 x 106. The same amount of tetramisole given twice, a first injection at the time of vaccination and a second 48 h later, resulted in a better immunizing process so that the ID50 for these mice, group 5, was increased to 2.0 x 106 (confidence limits from 1.6 x 106 to 2.5 x 106), a figure which significantly differed from all other findings in this experiment. The time schedule of injections of tetramisole to mice exerted a striking influence upon stimulation of Brucella vaccine activity by this drug. Indeed, tetramisole injected three times (group 3) or administered twice, a first injection 48 h before and a second simultaneously to vaccination (group 4), did not significantly modify the immunization brought about by H 38 vaccine alone, as demonstrated by the overlapping of confidence limits (Fig. 1) .
Effects of tetramisole treatments upon dose response curves. The dose response curve in group 2 mice immunized by H 38 vaccine alone did not parallel the curve obtained from unvaccinated, control mice (Fig. 1) Tetramisole, as well as its levogyre isomere, levamisole, inhibits succinate dehydrogenase activity (13) . This drug is devoid of blastogenic effects and inhibits alkaline phosphatase activity of various cell lines (unpublished data). All available data are suggestive for two different points of impact of tetramisole activities in immunocompetent cells (11) . We are well aware that basic studies are still needed to elucidate the mechanisms of tetramisole, or levamisole.
activities and the reasons for their unique ability to induce a specific immune enhancement more markedly and without any granuloma-producing effect if injected late after an antigenic stimulus.
To our knowledge, present data are the first to reveal a simple synthetic compound which could be able to induce an immune enhancement, especially if administered late after antigen. It may be possible to employ these phenylimidothiazole salts as nontoxic, chemically defined adjuvants to improve the usefulness of most vaccines.
